Uterine cancer affects almost 55,000 women a year. About 80 percent of uterine tumors are endometrial adenocarcinomas, cancers that start in the endometrium (the inner lining of the uterus). What many professionals call uterine cancer is uterine sarcoma, which makes up about two to four percent of uterine cancers.
Other rarer types of uterine cancers include:
Stromal tumors: Endometrial stromal sarcomas develop in the supporting connective tissue (stroma) of the endometrium. These cancers represent less than one percent of all uterine cancers. These tumors are low grade and tend to grow slowly.
Gestational trophoblastic tumors: This rare cancer develops inside the uterus in the tissues formed following conception.
Why Choose Sylvester Comprehensive Cancer Center?
One of only 71 NCI-designated cancer centers in the United States. Sylvester is one of only two cancer centers in Florida that have been recognized by the National Cancer Institute. The team earned this distinction through its outstanding work conducting research in its laboratories, treating patients in its clinics and hospitals, and reaching out to medically underserved communities with innovative prevention strategies.
More experienced physicians to care for you. Sylvester treats more than 5,000 patients with cancer each year. Your dedicated team of physicians at Sylvester have a huge depth and breadth of experience treating your unique cancer.
Multidisciplinary care teams provide nationally recognized expertise. Your physician experts talk to each other, face-to-face, on a regular basis and plan the right care for you and your specific cancer. And you can expect that caliber of care in years to come. Sylvester also has the only gynecologic oncology fellowship in South Florida training the next generation of doctors.
Fertility preservation experts. You don’t have to choose between future fertility and cancer treatment. Specialists at the University of Miami Fertility Center in the Department of Obstetrics and Gynecology offer fertility counseling for male and female cancer patients to help you explore your options and make decisions regarding fertility preservation before you undergo treatments such as chemotherapy or radiation therapy.